MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2017 International Congress

    The Use of Atypical Antipsychotics in Depression and Anxiety may Unmask Parkinson’s Disease: A Retrospective Chart Review

    K. Amodeo, R. Schneider, I. Richard (Rochester, NY, USA)

    Objective: Characterize the population with parkinsonism and exposure to antipsychotics who underwent dopamine transporter single-photon emission computed tomography (DATSPECT). Background: Atypical antipsychotics are used in …
  • 2017 International Congress

    Utility of DaTscan Imaging in Differentiating Drug Induced Parkinsonism from IPD and Other Forms of Parkinsonism

    M. Salgado, D. Panebianco, J. Muller, A. Ortega, S. (Brooklyn, NY, USA)

    Objective: To determine clinical correlates which differentiate drug induced Parkinsonism (DIP) from IPD and other forms of Parkinsonism using DaT-SPECT imaging. Background: DaT-SPECT imaging is…
  • 2017 International Congress

    Is Hypertension and Certain Anti Hypertensive Agents Increase The Risk of Parkinson Disease?

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: The aim of this study is measure the risk of PD related to hypertension and certain use of anti hypertensive treatment.   Background: Cardiovascular risk…
  • 2017 International Congress

    Transcranial sonography in the prognosis of drug-induced parkinsonism

    Y.-S. Oh, D.-Y. Kwon (Seoul, Republic of Korea)

    Objective: We investigated the substantia nigra (SN) echogenicity in drug-induced parkinsonism (DIP), Parkinson's disease (PD), and healthy controls. A subgroup analysis of DIP by clinical…
  • 2016 International Congress

    Neuronal nicotinamide-N-methyltransferase (NNMT) in Parkinson’s disease

    K. Schmeisser, A. Parker (Montreal, QC, Canada)

    Objective: Understanding the role of NNMT in initiation and progression of Parkinson's disease (PD). Background: 10-15% of all PD cases are caused by genetic factors,…
  • 2016 International Congress

    Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders

    M.V. Rey, L. Molina, B. Recinos, B. Paz, M. Rovelo, F.E. Rodriguez Elias, J. Calderon, A. Arellano, S. Pomata, S. Perez-Lloret, CA-APD Study Team (Buenos Aires, Argentina)

    Objective: To compare the risk of movement disorders with antipsychotic drugs (APDs) in patients suffering from Schizophrenia or Depressive Disorders. Background: APDs are well-known causes…
  • 2016 International Congress

    Frequency of echogenic abnormality of the substantia nigra is increased in methamphetamine users

    J.J. Rumpf, J. Albers, C. Fricke, D. Weise, J. Classen (Leipzig, Germany)

    Objective: To investigate structural abnormality of the substantia nigra (SN) in methamphetamine users using transcranial sonography (TCS). Background: Epidemiologic studies suggest that chronic use of…
  • 2016 International Congress

    Drug induced parkinsonism: Role of functional imaging and follow up

    A.S. Shetty, H.J. Shah, V.R. Lele, P.M. Wadia (Mumbai, India)

    Objective: Retrospective study of the outcome of patients with new onset parkinsonism with a history of exposure of a drug known to cause parkinsonism prior…
  • 2016 International Congress

    Valproate-induced reversible parkinsonism – A case series

    R.M. Simões, N. Inácio, V.B. Silva, A. Arraiolos, P. Alegria, N. Canas, J. Vale (Loures, Portugal)

    Objective: To describe a case series of valproate (VPA)-induced parkinsonism and increase awareness for this condition. Background: VPA as a cause of parkinsonism has been…
  • 2016 International Congress

    Effect of intra-striatal 6-OHDA lesion on extra-striatal structures in the mouse

    B. Becker, M. Demirbas, C. Beyer, S. Tan, M. Kipp (Aachen, Germany)

    Objective: Characterization of extra-striatal manifestations in the 6-hydroxydopamine (6-OHDA) Parkinson's disease (PD) animal model. Background: PD is a neurodegenerative disorder characterized by progressive loss of…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley